This site is new - feedback and suggestions welcome via GitHub issues.
0

Osimertinib, platinum, and etoposide for patients with metastatic EGFR/TP53/RB1-mutant lung cancers at risk for histological transformation. (science.org)

Authors: Gavarro LM … Yu HA Journal: Science Translational Medicine Published: 2026-11-11 DOI: https://doi.org/10.1126/scitranslmed.aee6618
submitted by robot 11d ago 0 comments

Comments

No comments yet. Be the first!